Anthem Biosciences Share Price Target From 2026 to 2030

Anthem Biosciences Share Price Target From 2026 to 2030: Anthem Biosciences is a contract research, development, and manufacturing organization that provides drug discovery, development, and large-scale production services. It supports pharmaceutical and biotechnology companies from initial research to commercial production. The company has GLP facilities for drug safety and efficacy testing. Anthem also specializes in the development of nutritional products and complex compounds. Here we will discuss ITC Hotels’ share price target from 2026 to 2030, fundamental analysis, and its shareholding pattern.

Anthem Biosciences Fundamental Analysis

Market Cap: ₹36,213 Cr.
ROE: 18.75%
P/E Ratio: 70.16
P/B Ratio: 13.16
Debt-to-Equity: 0.04
EPS (TTM): 9.19
Dividend Yield: 0%
Book Value: ₹49.01
Face Value: ₹2

Anthem Biosciences Share Price Target 2026

Anthem Biosciences has established a strong presence in the biotechnology and research services sector over the past few years. The company’s steadily growing demand and investment in research have maintained its stability. Analysts expect its share price to rise from approximately ₹630 to ₹680 in 2026. This indicates that the company’s growth momentum remains healthy. Investor confidence and management strategies could deliver better results in the future. If the market environment remains positive, this year could prove to be crucial for Anthem Biosciences’ performance.

Also Read: Silver ETF Share Price Target From 2026 to 2030

Anthem Biosciences Share Price Target 2027

Anthem Biosciences is expected to expand its research projects worldwide in 2027. The continued growth in demand for the company’s products and services is driving sustainable growth. The potential target price for its stock this year is estimated to be around ₹680 to ₹730. This range indicates that investors’ expectations for the company remain high. Increasing collaborations, new contracts, and technological advancements could further boost its earnings. Therefore, 2027 could prove to be a year full of opportunities for Anthem Biosciences.

Anthem Biosciences Share Price Target 2028

Anthem Biosciences could enter the next phase of its growth in 2028, particularly in pharmaceutical research and biotech collaborations. The company’s production capacity and focus on innovation offer long-term growth potential. The target price for its stock this year is expected to be between ₹730 and ₹780. This estimate suggests that the company can maintain its steady progress. This year represents balanced and reliable returns for investors. If the global business environment remains positive, Anthem Biosciences could reach significant growth.

Also Read: Doji Candlestick Pattern Explained: Meaning, Types, Trading Strategy, and How It Signals a Market Reversal

Anthem Biosciences Share Price Target 2029

When it comes to 2029, Anthem Biosciences is expected to further strengthen its market network. The company’s investment in research and development will keep it ahead of the competition. Its potential share price target this year is estimated to be between ₹780 and ₹840. This suggests that the company’s financial performance could remain stable and strong. Management’s strategic decisions and expanding global presence could propel it further upwards. Overall, 2029 could prove to be an attractive year for investment.

Anthem Biosciences Share Price Target 2030

The year 2030 could be a year of long-term success and maturity for Anthem Biosciences. During this time, the company could enter new markets through its research results and products. According to experts, its share price is expected to reach between ₹840 and ₹890 by 2030. This growth indicates that the company has made steady progress toward achieving its long-term goals. Strong fundamentals and experienced leadership will further stabilize it. Looking ahead, this year will be full of possibilities for Anthem Biosciences investors.

Also Read: Adani Power Share Price Target From 2026 to 2030